Back to R2 link
Top Industry News
- TGA Updated Guidelines for Assessed Listed Medicines
- PMDA About Medical Device Cybersecurity
- FDA Guidance on Data Integrity for In Vivo Bioavailability and Bioequivalence Studies
- EMA Scientific Advice Pilot for High-risk Medical Devices
- MHRA Guidance on Medicines: Apply for a Parallel Import Licence
- FDA Guidance on Electronic Submission of Expedited Safety Reports From IND-Exempt BA/BE Studies
- PMDA - The Information of New Drug Review with Electronic Data Updated
- The Ministry of Health Malaysia has Issued a Press release Urging the Public to Avoid Purchasing and Using Certain Cosmetic Products due to their Detection of Scheduled Poisons.
- Commencing January 1st, 2025, the state of Washington in the United States has Implemented the Toxic-Free Cosmetics Act, Which Bans Specific Substances and Oversees Lead Concentrations in Finalized Cosmetic Items.
- MHRA Assistive Technology: Definitions, Examples and Safe Use
- ANVISA is Launching a Public Consultation Process to Develop Guidelines for Nutritional Products, Including Infant Formulas, Follow-on Foods, Cereal-based Foods, Enteral Nutrition Formulas, and Dietotherapeutic Formulas for Inborn Metabolic Errors.
- Canada has published the Final Assessment and Management Approach for Thallium and its Compounds
- Health Canada's position on Gluten-Free Claims Requires that Foods labeled as gluten-free must comply with Section B.24.018 of the Food and Drug Regulations (FDR).
- PMDA About Usability of Medical Devices
- PMDA Notifications Regarding Safety Measures (Medical Devices)
- MHRA Guidance on Labelling and Packaging of Medicinal Products for Human use Following Agreement of the Windsor Framework